Cargando…
An overview of arsenic trioxide-involved combined treatment algorithms for leukemia: basic concepts and clinical implications
Arsenic trioxide is a first-line treatment drug for acute promyelocytic leukemia, which is also effective for other kinds of leukemia. Its side effects, however, limit its clinical application, especially for patients with complex leukemia symptoms. Combination therapy can effectively alleviate thes...
Autores principales: | Jiang, Yanan, Shen, Xiuyun, Zhi, Fengnan, Wen, Zhengchao, Gao, Yang, Xu, Juan, Yang, Baofeng, Bai, Yunlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374529/ https://www.ncbi.nlm.nih.gov/pubmed/37500645 http://dx.doi.org/10.1038/s41420-023-01558-z |
Ejemplares similares
-
The involvement and therapeutic potential of lncRNA Kcnq1ot1/miR-34a-5p/Sirt1 pathway in arsenic trioxide-induced cardiotoxicity
por: Shen, Xiuyun, et al.
Publicado: (2023) -
Correction: The involvement and therapeutic potential of lncRNA Kcnq1ot1/miR-34a-5p/Sirt1 pathway in arsenic trioxide-induced cardiotoxicity
por: Shen, Xiuyun, et al.
Publicado: (2023) -
Basic Mechanisms of Arsenic Trioxide (ATO)-Induced Apoptosis in Human Leukemia (HL-60) Cells
por: Yedjou, Clement, et al.
Publicado: (2010) -
A Review of Arsenic Trioxide and Acute Promyelocytic Leukemia
por: Alimoghaddam, Kamran
Publicado: (2014) -
On arsenic trioxide in the clinical treatment of acute promyelocytic leukemia
por: Zhang, Peng
Publicado: (2017)